溶解微针用于大脑输送:最近的进展和挑战
Kaustubh Ajit Kolekar1, Popat S Kumbhar2, Sukriti Vishwas1
1School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab 144411, India.
Drug discovery today
|March 14, 2025
概括
溶解微针 (DMNs) 提供了一种新的,无痛的脑药物输送方法,特别是在阿尔茨海默氏症和帕金森症等神经退行性疾病中. 本综述涵盖了DMN技术,临床进展以及大脑药物输送的挑战.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
- 神经科学是一个神经科学.
背景情况:
- 溶解微针 (DMN) 正在成为药物输送的重大进展.
- 它们提供一种最小侵入性的方法,用于局部和受控的管理.
- 对于易于口服降解的药物,DMN特别有用.
研究的目的:
- 审查DMN用于向大脑输送药物的应用.
- 讨论最近在DMN的技术创新.
- 探索神经系统疾病的DMN翻译的临床状态和挑战.
主要方法:
- 关于DMN技术用于大脑药物输送的文献评论.
- 分析鼻腔内,皮肤外和内输送途径.
- 在神经退行性疾病模型中检查DMN的应用.
主要成果:
- 通过多种途径,DMN证明了有效的药物输送到大脑.
- 最近的进展改善了DMN设计和药物加载能力.
- 目前正在探索DMN用于阿尔茨海默氏症和帕金森病的治疗.
结论:
- DMN代表了大脑药物输送的有希望的策略,特别是在神经疾病中.
- 需要进一步的技术开发和临床试验来克服翻译方面的挑战.
- 在神经退行性疾病中,DMN有可能改善治疗结果.
相关概念视频
01:16Drug Delivery: Overview
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...